EyePoint Pharmaceuticals
EYPT
$19.74
Share price
-1.00%
Change (1 day)
201.83%
Change (1 year)
Categories
EyePoint Pharmaceuticals (EYPT) - Total assets
Total assets on the balance sheet as of December 2023 : $0.35 B
According to EyePoint Pharmaceuticals 's latest financial reports the company's total assets are $0.35 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
EyePoint Pharmaceuticals - Total assets on balance sheet (from 2003 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.35 B | 96.93% |
| 2022-12-31 | $0.18 B | -31.52% |
| 2021-12-31 | $0.26 B | 187.16% |
| 2020-12-31 | $91.71 M | 25.69% |
| 2019-12-31 | $72.97 M | |
| 2018-06-30 | $71.67 M | 283.73% |
| 2017-06-30 | $18.67 M | -40.93% |
| 2016-06-30 | $31.61 M | -2.31% |
| 2015-06-30 | $32.36 M | 42.77% |
| 2014-06-30 | $22.67 M | 39.52% |
| 2013-06-30 | $16.24 M | -21.11% |
| 2012-06-30 | $20.59 M | -56.28% |
| 2011-06-30 | $47.11 M | 9.53% |
| 2010-06-30 | $43.01 M | 15.93% |
| 2009-06-30 | $37.1 M | -33.49% |
| 2008-06-30 | $55.78 M | -45.58% |
| 2007-06-30 | $0.10 B | -41.37% |
| 2006-06-30 | $0.17 B | 150.63% |
| 2005-06-30 | $69.76 M | 148.7% |
| 2004-06-30 | $28.05 M | 481.92% |
| 2003-06-30 | $4.82 M | |
| 2001-06-30 | $4.71 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $0.27 M | -99.92% | Bahamas |
 NRC Health
NRC | $0.12 B | -65.53% | 🇺🇸 USA |